Lessons from (patho)physiological tissue stiffness and their implications for drug screening, drug delivery and regenerative medicine

被引:32
|
作者
Chen, Wen Li Kelly [3 ]
Simmons, Craig A. [1 ,2 ]
机构
[1] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada
[2] Univ Toronto, Fac Dent, Toronto, ON M5S 3G8, Canada
[3] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Substrate stiffness; Elasticity; Biomechanics; Stem cells; Cancer biology; Mechanobiology; Biomaterials; FOCAL ADHESION KINASE; ACTIVATES LATENT TGF-BETA-1; GROWTH-FACTOR-BETA; CANCER CELL-LINES; STEM-CELLS; EXTRACELLULAR-MATRIX; SUBSTRATE STIFFNESS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; MALIGNANT PHENOTYPE;
D O I
10.1016/j.addr.2011.01.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diseased tissues are noted for their compromised mechanical properties, which contribute to organ failure; regeneration entails restoration of tissue structure and thereby functions. Thus, the physical signature of a tissue is closely associated with its biological function. In this review, we consider a mechanics-centric view of disease and regeneration by drawing parallels between in vivo tissue-level observations and corroborative cellular evidence in vitro to demonstrate the importance of the mechanical stiffness of the extracellular matrix in these processes. This is not intended to devalue the importance of biochemical signaling: in fact, as we discuss, many mechanical stiffness-driven processes not only require cooperation with biochemical cues, but they ultimately converge at common signaling cascades to influence cell and tissue function in an integrative manner. The study of how physical and biochemical signals collectively modulate cell function not only brings forth a more holistic understanding of cell (patho)biology, but it also creates opportunities to control material properties to improve culture platforms for research and drug screening and aid in the rationale design of biomaterials for molecular therapy and tissue engineering applications. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 50 条
  • [1] Sequential drug/gene delivery in tissue engineering & regenerative medicine
    Chew, Sing Yian
    ADVANCED DRUG DELIVERY REVIEWS, 2019, 149 : 1 - 1
  • [2] Bioresponsive drug delivery for regenerative medicine
    Park, Kinam
    JOURNAL OF CONTROLLED RELEASE, 2008, 130 (03) : 201 - 201
  • [3] Drug Delivery Design for Regenerative Medicine
    Wang, Xiaohong
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (12) : 1503 - 1505
  • [4] Drug Delivery and Regenerative Medicine Technology
    Lee, Hai Bang
    Jeong, Je Kyo
    Sohn, Se-il
    Byun, Youngro
    Ki, Min Hyo
    Seo, Jung-Ki
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 6 (4-11) : 663 - 667
  • [5] From kidney development to drug delivery and tissue engineering strategies in renal regenerative medicine
    Dankers, Patricia Y. W.
    Boomker, Jasper M.
    Meijer, E. W.
    Popa, Eliane R.
    van Luyn, Marja J. A.
    JOURNAL OF CONTROLLED RELEASE, 2011, 152 (01) : 177 - 185
  • [6] Cell responses to the mechanochemical microenvironment - Implications for regenerative medicine and drug delivery
    Rehfeldt, Florian
    Engler, Adam J.
    Eckhardt, Adam
    Ahmed, Fariyal
    Discher, Dennis E.
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (13) : 1329 - 1339
  • [8] Nanofibers in regenerative medicine and drug delivery Preface
    Chew, Sing Yian
    Park, Tae Gwan
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (12) : 987 - 987
  • [9] Nanomedicine and drug delivery systems in cancer and regenerative medicine
    Garbayo, Elisa
    Pascual-Gil, Simon
    Rodriguez-Nogales, Carlos
    Saludas, Laura
    Estella-Hermoso de Mendoza, Ander
    Blanco-Prieto, Maria J.
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2020, 12 (05)
  • [10] Drug Delivery Systems in Regenerative Medicine: An Updated Review
    Mansour, Alaa
    Romani, Maya
    Acharya, Anirudh Balakrishna
    Rahman, Betul
    Verron, Elise
    Badran, Zahi
    PHARMACEUTICS, 2023, 15 (02)